Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000280950 | SCV000330905 | uncertain significance | not provided | 2015-10-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001855077 | SCV002117686 | pathogenic | Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2021-05-05 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACADM protein function. This variant has been observed in individual(s) with MCAD deficiency (Invitae). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 280948). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with lysine at codon 225 of the ACADM protein (p.Glu225Lys). The glutamic acid residue is moderately conserved and there is a small physicochemical difference between glutamic acid and lysine. |